BUSINESS DAILY - Astrazeneca rejects Pfizer’s ‘final’ takeover offer
- 10 years ago
The Anglo-Swiss pharmaceutical firm Astrazeneca has rejected a new takeover bid from Pfizer, worth almost $119 billion. Pfizer says it won’t improve its offer further, nor will it proceed to a hostile takeover by approaching shareholders directly. Also today: Nutella, the staple of French breakfast tables, celebrates its 50th birthday.
Visit our website:
http://www.france24.com
Like us on Facebook:
https://www.facebook.com/FRANCE24.English
Follow us on Twitter:
https://twitter.com/France24_en
Visit our website:
http://www.france24.com
Like us on Facebook:
https://www.facebook.com/FRANCE24.English
Follow us on Twitter:
https://twitter.com/France24_en